DA (Daunorubicin) and Ara-C for Acute Myeloid Leukaemia

Regular price £0.00

Tax included.

What's in the booklet?

In this booklet we focus on DA treatment, the combination of daunorubicin and ara-C, also known as cytarabine, as well as the liposomal formulation of daunorubicin and cytarabine (also known as CPX-351 or Vyxeos). Although some healthcare professionals may use the term ara-C when referring to the generic drug cytarabine, we will use cytarabine throughout this booklet.

Acute myeloid leukaemia (AML) is one of the types of leukaemia where patients produce too many immature myeloid blast cells. Blast cells are immature cells found in the bone marrow which are not fully developed. This type of leukaemia progresses rapidly. To know more about the symptoms and diagnosis of AML, please view our booklet titled Acute Myeloid Leukaemia (AML).

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Add donation